The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Annual Report 2018

The EDCTP 2018 Annual Report has been published in a new digital format.

Introductions by Dr Mark Palmer, Dr Michael Makanga, portfolio infographics and project highlights. As PDF downloads: Financial Statements 2018 and Summary Annual Report 2018

 

Also via Publications

EDCTP 2003-2018

Overview of selected EDCTP-funded clinical studies for medical interventions against poverty-related infectious diseases, 2003-2018. EDCTP succeeds in bringing together researchers and institutions in Europe and Africa.

Read more

EDCTP Fellows

The EDCTP Alumni Network has a digital platform to connect and facilitate the collaboration of former and current EDCTP fellows. The Alumni Network was launched in 2017 and the platform in 2018.

Read more publications

Latest news

17 October 2019

Annual Report 2018 – a strong portfolio halfway EDCTP2

EDCTP published its Annual Report 2018 – 15th anniversary of the EDCTP programme in a new digital format. The report gives a quick overview of the milestones in the development of the partnership since 2003 and presents the strong EDCTP2…

Read more
4 October 2019

EDCTP invests €18 million in evaluation of candidate malaria vaccine portfolio

EDCTP awarded a grant of EUR 18 million to an international consortium to evaluate a portfolio of three innovative candidate malaria vaccines that aim to block transmission of the Plasmodium falciparum parasite. The PfTBV consortium is coordinated by Dr Issaka…

Read more